|
|
Blood, 15 December 2006, Vol. 108, No. 13, pp. 4035-4044.
Prepublished online as a Blood First Edition Paper on August 29, 2006; DOI 10.1182/blood-2006-05-023739.
Previous Article | Next Article 
Submitted May 17, 2006
Accepted August 4, 2006
PKC regulates collagen-induced platelet aggregation through inhibition of VASP-mediated filopodia formation
Giordano Pula, Kai Schuh, Keiko Nakayama, Keiichi I Nakayama, Ulrich Walter, and Alastair W. Poole*
University of Bristol, UK
Institute for Clinical Biochemistry, Wuerzburg, Germany
Tohoku University, Japan
Kyushu University, Japan
* Corresponding author; email: a.poole{at}bris.ac.uk.
Protein kinase C (PKC ) has been shown by pharmacological approaches to negatively regulate collagen-induced platelet aggregation. Here we addressed the molecular and cellular mechanisms underlying this negative regulation. Using PKC -/- platelets, we show that the mechanism did not involve altered inside-out signaling to integrin IIb 3 and did not affect early signaling events downstream of GP VI, since there was no difference in tyrosine phosphorylation of PLC 2 between wild type and PKC -/- platelets. There was also no increase in secretion of dense granule content, in contrast to studies using rottlerin where secretion was enhanced. Importantly however there was marked enhancement of filopodia generation in PKC -/- platelets upon adhesion to collagen, compared to wild type platelets. Filopodia play an essential role regulating adhesive events leading to platelet aggregation, by increasing platelet-platelet contact. We show that the critical effector for PKC is vasodilator-stimulated phosphoprotein (VASP), a major regulator of actin cytoskeleton dynamics. PKC physically interacts with VASP constitutively, and regulates its phosphorylation on Ser157. In VASP-/- platelets, the enhancement of filopodia generation, actin polymerisation and platelet aggregation by rottlerin is ablated. PKC is therefore a critical negative regulator of filopodia, and hence platelet aggregation, through a functional interaction with the actin organizer VASP.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Uncovering the dark side of PKC
- Ulhas P. Naik
Blood 2006 108: 3959-3960.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
P. M. Benz, C. Blume, S. Seifert, S. Wilhelm, J. Waschke, K. Schuh, F. Gertler, T. Munzel, and T. Renne
Differential VASP phosphorylation controls remodeling of the actin cytoskeleton
J. Cell Sci.,
November 1, 2009;
122(21):
3954 - 3965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. P. Naik
Lyn and PKC{delta} order SHIP1 embargo
Blood,
October 1, 2009;
114(14):
2856 - 2857.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. F. Neel, M. Barzik, D. Raman, T. Sobolik-Delmaire, J. Sai, A. J. Ham, R. L. Mernaugh, F. B. Gertler, and A. Richmond
VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis
J. Cell Sci.,
June 1, 2009;
122(11):
1882 - 1894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Chari, T. Getz, B. Nagy Jr, K. Bhavaraju, Y. Mao, Y. S. Bynagari, S. Murugappan, K. Nakayama, and S. P. Kunapuli
Protein Kinase C{delta} Differentially Regulates Platelet Functional Responses
Arterioscler Thromb Vasc Biol,
May 1, 2009;
29(5):
699 - 705.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|